Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank13
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-128.34M
↓ 76% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-72.84M
Historical baseline
PeriodValueYoY Change
TTM$-128.34M+17.5%
2024$-155.50M-33.6%
2023$-116.36M-23.0%
2022$-94.63M-25.4%
2021$-75.44M-102.4%
2020$-37.27M-1255.3%
2019$-2.75M+90.3%
2018$-28.33M-67.4%
2017$-16.92M-